A 62-year-old female with diffuse pulmonary amyloidosis developed abnormal radiographic findings while under observation for hyperimmunoglobulinemiaover a ten-year period. Serum immunoglobulin G (IgG) was elevated (4,620 mg/dl), and associated with monoclonal gammopathy (M protein) of the kappa type, but no evident abnormalities were apparent in bone marrow. Chest radiograph and computed tomography showed a diffuse reticulonodular shadow in the bilateral lung. Thoracoscopic lung biopsy specimen revealed depositions of amyloid in the bronchus and pulmonary vessel. Weemphasize that diffuse pulmonary amyloidosis should be considered a possible diagnosis in the presence of monoclonal immunoglobulin.
Introduction
Diffuse pulmonary amyloidosis is one form of pulmonary deposition of amyloid. This type of pulmonary amyloidosis usually occurs in association with primary amyloidosis, and is considered to be the least commonform of pulmonary amyloidosis (1) (2) (3) (4) (5) (6) (7) (8) . Several pathological studies have revealed that pulmonary involvement with amyloid in patients with primary amyloidosis is more frequent than has been suspected clinically (1) (2) (3) (4) (5) .* Clinical cases which produced respiratory symptoms without cardiac amyloidosis-related clinical manifestation are rare. Wepresent a case of diffuse alveolar septal amyloidosis which shows clinical significance. The patient has been observed for over ten years for an elevated level ofimmunoglobulin (Ig), and has developed abnormal radiographic findings.
Case Report
A 62-year-old nonsmoking female was referred to our hospital on December 1994 because of cough and sputum. She underwent left lower lobectomy for pseudolymphoma in 1982, and was diagnosed with hypergammaglobulinemia at that time. However,repeated examinations of bone marrowaspirations showed no abnormal findings. The values of y-globulin (IgA; 464-771 mg/dl, IgG; 3,311^,795 mg/dl) have been stable since the operation. Physical examinations revealed no abnormal findings, but chest radiograph showed an interstitial shadow on bilateral lungs. Her symptomsand chest radiographic findings did not improve. She was admitted to our hospital on July 14, 1 995 for furtherexamination. Laboratory data on admission are summarized in Table 1 neutrophils; 2%, eosinophils; 0% and CD4/CD8; 1.96). Chest radiograph showed a diffuse reticulonodular shadow in bilateral lungs, and post-lobectomic change in the left lower lung field (Fig. 1) . Chest computed tomography (CT) showed multiple small nodular shadows along the bilateral bronchovascular bundle, thickening of interlobular septum and bronchiole, and bronchiectasis (Fig. 2) . Bone marrowexamination showed no abnormal proliferation of plasma cells. Thoracoscopic lung biopsy from the right middle (S4) and lower lobes (S8) was performed. Two lung biopsy specimens showed identical histological findings (Fig. 3) , and revealed that the bronchial walls were thickened, an eosinophilic amorphismicsubstance had invaded the alveolus most prevalently around the bronchus and vessel, and monocytes and giant cells were invasive but no dysplasia was seen. The amorphismic substance was stained by congo red and not digested by potassium permanganate. Thus, it was thought to be an immunoglobulin-derived amyloid (AL protein). Immunohistochemical staining confirmed that it was kappa type, identical to the protein in the serum.
Discussion
Diffuse parenchymal amyloidosis is usually associated with systemic conditions, such as primary amyloidosis or multiple Pulmonary Amyloidosis and Monoclonal Gammopathy Figure 3 . The resected lung specimens showed thatan eosinophilic amorphismic substance was deposited around the bronchus and vessel, and the monocytes and giant cells were invasive (HE stain, x40).
myeloma (1) (2) (3) (4) (5) (6) (7) (8) . The involvement of respiratory tissue is pathologically common in immunoglobulin-derived amyloidosis, but it rarely becomes clinically significant (1-6). Amyloid deposition in the heart and/or kidney has been thought to be a factor in patients with primary amyloidosis, and cardiac or renal function is an important prognostic indicator (1-4, 6, 9, 10). Pulmonaryinvolvement tends to mirror the cardiac manifestations both in frequency and in extent (6) , but the evidence of pulmonary amyloidosis is mainly found at autopsy (1-6).
Several authors have described cases with diffuse parenchymal pulmonary amyloidosis who had severe respiratory impairment (1) (2) (3) (4) (5) (6) 8) . These cases were found to have amyloid deposition in the pulmonary interstitial structure, especially in the gas exchange zones. These cases had an unfavorable prognosis with a survival of approximately one year; the death was due to respiratory failure. The histological findings in the present case showed muchless deposition ofamyloidosis in the gas exchange zone, especially in the pulmonary capillaries, compared to previous reports. The severity of amyloid deposition in pulmonary capillaries is likely to correlate with pulmonary impairment (7) . Indeed, the present case showed a normal partial oxygen tension. Furthermore, no remarkable changes in chest radiographic findings and blood gas analysis have been observed since diagnosis over one year ago. Unfortunately, in the present case wecan not rule out the possible involvementof amyloidosis in other organs, because of her private reason. The patient remains asymptomaticin related amyloid deposition of the non-pulmonary organs. Based on the clinical course and histological examination of the present case, long-term survival is a possibility.
The present case developed a diffuse radiographic presentation during a ten-year follow-up ofhyperimmunoglobulinemia. She had detectable monoclonal immunoglobulin with kappa light chain in the serum, and had a history of lobectomy for pseudolymphoma.There are a few reports in which lymphoma cell was responsible for the deposition of light chain amyloidosis (1 1, 12 ). Weexamined the resected lung specimen obtained during the operation for pseudolymphoma, but found no evidence of amyloid deposition. Furthermore, the degree of hyperimmunoglobulin has unchanged even after the resection of pseudolymphoma. Based on these clinical findings, we speculated that the amyloid deposition in the present case was independent of the previously existing pseudolymphoma. The precise mechanismsof amyloidogenesis are still unclear. In addition, we do not know why pulmonary involvement is dominant or clinically significant in our case. Further observations and studies are needed. In the related literature, there was no correlation between the presence of M component and a prevalence or pattern of pulmonary amyloidosis.
The radiographic abnormalities and clinical features in diffuse parenchymal amyloidosis are frequently confused with those of pulmonary flbrosis. Plasma immunoglobulinsare sometimes elevated in patients with pulmonary flbrosis, although the findings are nonspecific. It should be taken into consideration that the diffuse interstitial type of amyloidosis is an important disease which should be distinguished from pulmonary flbrosis, especially in the presence of monoclonal gammopathy.
